Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 5:2019:18-0131.
doi: 10.1530/EDM-18-0131. Online ahead of print.

Hyperglycemic hyperosmolar state in an adolescent with type 1 diabetes mellitus

Affiliations

Hyperglycemic hyperosmolar state in an adolescent with type 1 diabetes mellitus

Suguru Watanabe et al. Endocrinol Diabetes Metab Case Rep. .

Abstract

Hyperglycemic hyperosmolar state (HHS) and diabetic ketoacidosis (DKA) are the most severe acute complications of diabetes mellitus (DM). HHS is characterized by severe hyperglycemia and hyperosmolality without significant ketosis and acidosis. A 14-year-old Japanese boy presented at the emergency room with lethargy, polyuria and polydipsia. He belonged to a baseball club team and habitually drank sugar-rich beverages daily. Three weeks earlier, he suffered from lassitude and developed polyuria and polydipsia 1 week later. He had been drinking more sugar-rich isotonic sports drinks (approximately 1000-1500 mL/day) than usual (approximately 500 mL/day). He presented with HHS (hyperglycemia (1010 mg/dL, HbA1c 12.3%) and mild hyperosmolality (313 mOsm/kg)) without acidosis (pH 7.360), severe ketosis (589 μmol/L) and ketonuria. He presented HHS in type 1 diabetes mellitus (T1DM) with elevated glutamate decarboxylase antibody and islet antigen 2 antibody. Consuming beverages with high sugar concentrations caused hyperglycemia and further exacerbates thirst, resulting in further beverage consumption. Although he recovered from HHS following intensive transfusion and insulin treatment, he was significantly sensitive to insulin therapy. Even the appropriate amount of insulin may result in dramatically decreasing blood sugar levels in patients with T1DM. We should therefore suspect T1DM in patients with HHS but not those with obesity. Moreover, age, clinical history and body type are helpful for identifying T1DM and HHS. Specifically, drinking an excess of beverages rich in sugars represents a risk of HHS in juvenile/adolescent T1DM patients. Learning points: Hyperglycemic hyperosmolar state (HHS) is characterized by severe hyperglycemia and hyperosmolality without significant ketosis and acidosis. The discrimination between HHS of type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) in initial presentation is difficult. Pediatrician should suspect T1DM in patients with HHS but not obesity. Age, clinical history and body type are helpful for identifying T1DM and HHS. Children with T1DM are very sensitive to insulin treatment, and even appropriate amount of insulin may result in dramatically decreasing blood sugar levels.

Keywords: 2019; Adolescent/young adult; Anti-islet cell antibody; Asian - Japanese; BMI; Beta-hydroxybutyrate; C-peptide (blood); Dehydration; Diabetes; Diabetes mellitus type 1; Diet; Emergency; Fatigue; GADA; General practice; Glucose (blood); Haemoglobin A1c; Hyperglycaemia; Hyperosmolar hyperglycaemic state; Insulin; Japan; Ketones (plasma); Male; March; Paediatric endocrinology; Paediatrics; Pancreas; Polydipsia; Polyuria; Saline; Ultrasound scan; Unique/unexpected symptoms or presentations of a disease; Weight; Weight loss.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patient blood glucose levels after hospitalization in a patient with T1DM who developed HHS.

References

    1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003. 26 (Supplement 1) S5–S20. - PubMed
    1. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 1997. 350 1288–1293. (10.1016/S0140-6736(97)03062-6) - DOI - PubMed
    1. Gale EA, Bingley PJ, Emmett CL, Collier T. & European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. European nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 2004. 363 925–931. (10.1016/S0140-6736(04)15786-3) - DOI - PubMed
    1. Hagopian WA, Lernmark A, Rewers MJ, Simell OG, She JX, Ziegler AG, Krischer JP, Akolkar B. TEDDY – the environmental determinants of diabetes in the young: an observational clinical trial. Annals of the New York Academy of Sciences 2006. 1079 320–326. (10.1196/annals.1375.049) - DOI - PubMed
    1. Törn C, Mueller PW, Schlosser M, Bonifacio E, Bingley PJ. & Participating Laboratories. Diabetes antibody standardization program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 2008. 51 846–852. (10.1007/s00125-008-0967-2) - DOI - PubMed

LinkOut - more resources